JP2016210758A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016210758A5 JP2016210758A5 JP2015227257A JP2015227257A JP2016210758A5 JP 2016210758 A5 JP2016210758 A5 JP 2016210758A5 JP 2015227257 A JP2015227257 A JP 2015227257A JP 2015227257 A JP2015227257 A JP 2015227257A JP 2016210758 A5 JP2016210758 A5 JP 2016210758A5
- Authority
- JP
- Japan
- Prior art keywords
- auxiliary
- mass
- component
- auxiliary component
- total mass
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims 17
- 229940078795 Lactoferrin Drugs 0.000 claims 16
- 102000010445 Lactoferrin Human genes 0.000 claims 16
- 108010063045 Lactoferrin Proteins 0.000 claims 16
- OYPRJOBELJOOCE-UHFFFAOYSA-N calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims 16
- 229910052791 calcium Inorganic materials 0.000 claims 16
- 239000011575 calcium Substances 0.000 claims 16
- 239000004615 ingredient Substances 0.000 claims 16
- 235000021242 lactoferrin Nutrition 0.000 claims 16
- 229920001542 oligosaccharide Polymers 0.000 claims 16
- 150000002482 oligosaccharides Polymers 0.000 claims 16
- 239000003814 drug Substances 0.000 claims 6
- 229940079593 drugs Drugs 0.000 claims 6
- 239000002537 cosmetic Substances 0.000 claims 4
- 235000011194 food seasoning agent Nutrition 0.000 claims 4
- 239000000843 powder Substances 0.000 claims 4
- 229940054534 Ophthalmic Solution Drugs 0.000 claims 3
- 208000004371 Toothache Diseases 0.000 claims 3
- 235000013361 beverage Nutrition 0.000 claims 3
- 239000003795 chemical substances by application Substances 0.000 claims 3
- 238000004140 cleaning Methods 0.000 claims 3
- 235000013305 food Nutrition 0.000 claims 3
- 239000000463 material Substances 0.000 claims 3
- 239000002997 ophthalmic solution Substances 0.000 claims 3
- 210000000214 Mouth Anatomy 0.000 claims 2
- 229940100656 Nasal Solution Drugs 0.000 claims 2
- 210000003491 Skin Anatomy 0.000 claims 2
- BAQAVOSOZGMPRM-JVFSCRHWSA-N (2R,3R,4R,5R,6R)-2-[(2S,3R,4R,5R)-2,5-bis(chloromethyl)-3,4-dihydroxyoxolan-2-yl]oxy-5-chloro-6-(hydroxymethyl)oxane-3,4-diol Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@]1(CCl)[C@H](O)[C@@H](O)[C@H](CCl)O1 BAQAVOSOZGMPRM-JVFSCRHWSA-N 0.000 claims 1
- 229940057428 LACTOPEROXIDASE Drugs 0.000 claims 1
- 102000028880 Lactoperoxidase Human genes 0.000 claims 1
- 108010023244 Lactoperoxidase Proteins 0.000 claims 1
- 229940097496 Nasal Spray Drugs 0.000 claims 1
- 239000004376 Sucralose Substances 0.000 claims 1
- 239000008406 cosmetic ingredient Substances 0.000 claims 1
- 239000003889 eye drop Substances 0.000 claims 1
- 239000008187 granular material Substances 0.000 claims 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims 1
- 229910052749 magnesium Inorganic materials 0.000 claims 1
- 239000011777 magnesium Substances 0.000 claims 1
- 150000002681 magnesium compounds Chemical class 0.000 claims 1
- 239000007922 nasal spray Substances 0.000 claims 1
- 239000002667 nucleating agent Substances 0.000 claims 1
- 239000000243 solution Substances 0.000 claims 1
- 235000019408 sucralose Nutrition 0.000 claims 1
Claims (28)
上記補助成分は、当該補助成分全質量に対する質量％で、リン酸化オリゴ糖カルシウム：１〜３０％、ラクトフェリン：０．０１〜１０％を含有すること
を特徴とする点眼薬液。 Contains eye drop ingredients and auxiliary ingredients,
The said auxiliary component is the mass% with respect to the said auxiliary component total mass, and contains phosphorylated oligosaccharide calcium: 1-30%, lactoferrin: 0.01-10%.
を特徴とする請求項１記載の点眼薬液。 The ophthalmic solution according to claim 1, wherein the auxiliary component is contained in an amount of 0.1 to 100% by mass% with respect to the total mass of the ophthalmic solution.
を特徴とする請求項１又は２記載の点眼薬液。 3. The ophthalmic solution according to claim 1, wherein the phosphorylated oligosaccharide calcium and the lactoferrin in the auxiliary component are stored in advance in different containers and can be separately instilled.
上記補助成分は、当該補助成分全質量に対する質量％で、リン酸化オリゴ糖カルシウム：１〜３０％、ラクトフェリン：０．０１〜１０％を含有すること
を特徴とする点鼻薬液。 Containing a nasal drug component and an auxiliary component,
The said auxiliary component is the mass% with respect to the said auxiliary component total mass, and contains phosphorylated oligosaccharide calcium: 1-30%, lactoferrin: 0.01-10%.
を特徴とする請求項４記載の点鼻薬液。 The nasal solution according to claim 4, wherein the auxiliary component is contained in an amount of 0.1 to 100% by mass% with respect to the total mass of the nasal solution.
を特徴とする請求項４又は５記載の点鼻薬液。 The nasal spray solution according to claim 4 or 5, wherein the phosphorylated oligosaccharide calcium and the lactoferrin in the auxiliary component are stored in different containers in advance and can be separately nasalized.
上記補助成分は、当該補助成分全質量に対する質量％で、リン酸化オリゴ糖カルシウム：１〜３０％、ラクトフェリン：０．０１〜１０％を含有すること
を特徴とする化粧料。 Contains cosmetic ingredients and auxiliary ingredients,
Cosmetics characterized in that the auxiliary component is in mass% with respect to the total mass of the auxiliary component and contains phosphorylated oligosaccharide calcium: 1 to 30% and lactoferrin: 0.01 to 10%.
を特徴とする請求項７記載の化粧料。 The cosmetic according to claim 7, wherein the auxiliary component is contained in an amount of 0.1 to 100% by mass% based on the total mass of the cosmetic.
を特徴とする請求項７又は８記載の化粧料。 The cosmetic according to claim 7 or 8, wherein the phosphorylated oligosaccharide calcium and the lactoferrin in the auxiliary component are stored in advance in different containers and can be treated separately.
上記補助成分は、当該補助成分全質量に対する質量％で、リン酸化オリゴ糖カルシウム：１〜３０％、ラクトフェリン：０．０１〜１０％を含有すること
を特徴とする錠剤。 Contains pharmaceutical ingredients and auxiliary ingredients,
The said auxiliary component is the mass% with respect to the said auxiliary component total mass, and contains phosphorylated oligosaccharide calcium: 1-30%, lactoferrin: 0.01-10%. The tablet characterized by the above-mentioned.
を特徴とする請求項１０記載の錠剤。 The tablet according to claim 10, wherein the auxiliary component is coated on the surface of a nucleating agent containing the drug component.
を特徴とする請求項１０又は１１記載の錠剤。 The tablet according to claim 10 or 11, wherein the auxiliary component is contained in an amount of 0.1 to 100% by mass% based on the total mass of the tablet.
上記補助成分は、当該補助成分全質量に対する質量％で、リン酸化オリゴ糖カルシウム：１〜３０％、ラクトフェリン：０．０１〜１０％を含有すること
を特徴とする粉体又は顆粒状薬剤。 Both contain a drug component consisting of powder or granules, and an auxiliary component,
The auxiliary component is a powder or granular drug characterized by containing phosphorylated oligosaccharide calcium: 1 to 30% and lactoferrin: 0.01 to 10% in mass% with respect to the total mass of the auxiliary component.
を特徴とする請求項１３記載の粉体又は顆粒状薬剤。 The powder or granular drug according to claim 13, wherein the auxiliary component is contained in an amount of 0.1 to 100% by mass% based on the total mass of the powder or granular drug.
上記補助成分は、当該補助成分全質量に対する質量％で、リン酸化オリゴ糖カルシウム：１〜３０％、ラクトフェリン：０．０１〜１０％を含有すること
を特徴とする皮膚又は毛髪用洗浄剤組成物。 Contains cleaning ingredients and auxiliary ingredients,
The above-mentioned auxiliary component is a mass% with respect to the total mass of the auxiliary component and contains phosphorylated oligosaccharide calcium: 1 to 30%, lactoferrin: 0.01 to 10%. .
を特徴とする請求項１５記載の皮膚又は毛髪用洗浄剤組成物。 16. The skin or hair cleaning composition according to claim 15, wherein the auxiliary component is contained in an amount of 0.1 to 100% by mass based on the total mass of the skin or hair cleaning composition.
上記補助成分は、当該補助成分全質量に対する質量％で、リン酸化オリゴ糖カルシウム：１〜３０％、ラクトフェリン：０．０１〜１０％を含有すること
を特徴とする毛髪処理料。 Contains hair treatment ingredients and auxiliary ingredients,
The said auxiliary | assistant component is the mass% with respect to the said auxiliary | assistant component total mass, and contains phosphorylated oligosaccharide calcium: 1-30%, lactoferrin: 0.01-10%, The hair treatment material characterized by the above-mentioned.
を特徴とする請求項１７記載の毛髪処理料。 The hair treatment material according to claim 17, wherein the auxiliary component is contained in an amount of 0.1 to 100% by mass% based on the total mass of the hair treatment material.
上記補助成分は、当該補助成分全質量に対する質量％で、リン酸化オリゴ糖カルシウム：１〜３０％、ラクトフェリン：０．０１〜１０％を含有すること
を特徴とする食料組成物。 Contains edible ingredients and auxiliary ingredients,
The said auxiliary | assistant component is the mass% with respect to the said auxiliary | assistant component total mass, Phosphorylated oligosaccharide calcium: 1-30%, Lactoferrin: 0.01-10%, The food composition characterized by the above-mentioned.
を特徴とする請求項１９記載の食料組成物。 20. The food composition according to claim 19, wherein the auxiliary component is contained in an amount of 0.1 to 100% by mass% based on the total mass of the food composition.
上記補助成分は、当該補助成分全質量に対する質量％で、リン酸化オリゴ糖カルシウム：１〜３０％、ラクトフェリン：０．０１〜１０％を含有すること
を特徴とする飲料組成物。 Contains beverage ingredients and auxiliary ingredients,
The said auxiliary | assistant component is the mass% with respect to the said auxiliary | assistant component total mass, and contains phosphorylated oligosaccharide calcium: 1-30%, lactoferrin: 0.01-10%. The drink composition characterized by the above-mentioned.
を特徴とする請求項２１記載の飲料組成物。 The beverage composition according to claim 21, wherein the auxiliary component is contained in an amount of 0.1 to 100% by mass% based on the total mass of the beverage composition.
上記補助成分は、当該補助成分全質量に対する質量％で、リン酸化オリゴ糖カルシウム：１〜３０％、ラクトフェリン：０．０１〜１０％を含有すること
を特徴とする調味料組成物。 Contains seasoning ingredients and auxiliary ingredients,
The said auxiliary | assistant component is the mass% with respect to the said auxiliary | assistant component total mass, and contains phosphorylated oligosaccharide calcium: 1-30%, lactoferrin: 0.01-10%, The seasoning composition characterized by the above-mentioned.
を特徴とする請求項２３記載の調味料組成物。 24. The seasoning composition according to claim 23, wherein the auxiliary component is contained in an amount of 0.1 to 100% by mass% relative to the total mass of the seasoning composition.
組成物全質量に対する質量％で、
リン酸化オリゴ糖カルシウム：１〜３０％、
ラクトフェリン：０．０１〜１０％、
マグネシウム化合物：マグネシウム換算値で１〜５％を含有すること
を特徴とする口腔ケア組成物。 In an oral care composition that promotes oral health by including in the oral cavity,
% By weight relative to the total weight of the composition,
Phosphorylated oligosaccharide calcium: 1-30%
Lactoferrin: 0.01-10%
Magnesium compound: An oral care composition comprising 1 to 5% in terms of magnesium.
組成物全質量に対する質量％で、
リン酸化オリゴ糖カルシウム：１〜３０％、
ラクトフェリン：０．０１〜１０％、
スクラロース：１〜５％を含有すること
を特徴とする口腔ケア組成物。 In an oral care composition that promotes oral health by including in the oral cavity,
% By weight relative to the total weight of the composition,
Phosphorylated oligosaccharide calcium: 1-30%
Lactoferrin: 0.01-10%
Oral care composition characterized by containing sucralose: 1 to 5%.
上記補助成分は、当該補助成分全質量に対する質量％で、リン酸化オリゴ糖カルシウム：１〜３０％、ラクトフェリン：０．０１〜１０％、ラクトパーオキシターゼ：１〜２０％を含有すること
を特徴とする歯痛緩和剤。 Contains auxiliary ingredients,
The auxiliary component is characterized by containing phosphorylated oligosaccharide calcium: 1 to 30%, lactoferrin: 0.01 to 10%, and lactoperoxidase: 1 to 20% in mass% based on the total mass of the auxiliary component. Tooth pain relieving agent.
を特徴とする請求項２７記載の歯痛緩和剤。 28. The tooth pain relieving agent according to claim 27, wherein the auxiliary component is contained in an amount of 0.1 to 100% by mass% relative to the total mass of the tooth pain relieving agent.
Priority Applications (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16786138.4A EP3290041B1 (en) | 2015-04-27 | 2016-04-25 | Oral care composition |
| CN201680024188.0A CN107530367A (en) | 2015-04-27 | 2016-04-25 | Oral care composition |
| AU2016255815A AU2016255815B2 (en) | 2015-04-27 | 2016-04-25 | Oral care composition |
| MYPI2017704002A MY186889A (en) | 2015-04-27 | 2016-04-25 | Oral care composition |
| US15/568,442 US20180117070A1 (en) | 2015-04-27 | 2016-04-25 | Oral care composition |
| SG11201708597VA SG11201708597VA (en) | 2015-04-27 | 2016-04-25 | Oral care composition |
| PCT/JP2016/002171 WO2016174861A1 (en) | 2015-04-27 | 2016-04-25 | Oral care composition |
| HK18110971.2A HK1251470A1 (en) | 2015-04-27 | 2018-08-27 | Oral care compositon |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2015095075 | 2015-05-07 | ||
| JP2015095075 | 2015-05-07 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016210758A JP2016210758A (en) | 2016-12-15 |
| JP2016210758A5 true JP2016210758A5 (en) | 2017-11-16 |
| JP6256770B2 JP6256770B2 (en) | 2018-01-10 |
Family
ID=57550478
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015227257A Active JP6256770B2 (en) | 2015-04-27 | 2015-11-20 | Oral care composition, tablets, granular drugs |
| JP2016070214A Pending JP2016210762A (en) | 2015-04-27 | 2016-03-31 | Hypothermia ameliorating agent |
| JP2016089763A Expired - Fee Related JP6570124B2 (en) | 2015-05-07 | 2016-04-27 | Oral care composition |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016070214A Pending JP2016210762A (en) | 2015-04-27 | 2016-03-31 | Hypothermia ameliorating agent |
| JP2016089763A Expired - Fee Related JP6570124B2 (en) | 2015-05-07 | 2016-04-27 | Oral care composition |
Country Status (1)
| Country | Link |
|---|---|
| JP (3) | JP6256770B2 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6256770B2 (en) * | 2015-05-07 | 2018-01-10 | ジャパンモード株式会社 | Oral care composition, tablets, granular drugs |
| JP7272214B2 (en) * | 2019-09-24 | 2023-05-12 | 日油株式会社 | Dental plaque/stain adhesion inhibitor and oral composition |
| EP4331591A1 (en) * | 2021-12-15 | 2024-03-06 | Geihoku Pharmacy Co., Ltd. | Water-soluble composition and production method thereof |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1736388B (en) * | 2001-02-28 | 2010-04-14 | 江崎格力高株式会社 | Compositions having anti-dental caries function |
| JP2002322088A (en) * | 2001-04-24 | 2002-11-08 | Kakunai Juyotai Kenkyusho:Kk | Preparation for applying onto oral cavity |
| JPWO2005084703A1 (en) * | 2004-03-09 | 2007-11-29 | 株式会社Ｎｒｌファーマ | Sustained release oral composition |
| JP2007332072A (en) * | 2006-06-15 | 2007-12-27 | Snow Brand Milk Prod Co Ltd | Agent for maintaining enamel hardness |
| WO2010061932A1 (en) * | 2008-11-28 | 2010-06-03 | 江崎グリコ株式会社 | Food and composition each comprising phosphorylated sccharide, polyphenol and fluorine |
| JP5747274B1 (en) * | 2015-01-26 | 2015-07-08 | ジャパンモード株式会社 | Oral care composition |
| JP6256770B2 (en) * | 2015-05-07 | 2018-01-10 | ジャパンモード株式会社 | Oral care composition, tablets, granular drugs |
| JP5924604B1 (en) * | 2015-04-27 | 2016-05-25 | ジャパンモード株式会社 | Oral care composition |
| JP6570112B2 (en) * | 2015-06-18 | 2019-09-04 | ジャパンモード株式会社 | Pharmaceutical manufacturing method |
-
2015
- 2015-11-20 JP JP2015227257A patent/JP6256770B2/en active Active
-
2016
- 2016-03-31 JP JP2016070214A patent/JP2016210762A/en active Pending
- 2016-04-27 JP JP2016089763A patent/JP6570124B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Trukhachev et al. | Development of technology for food for people with hypersthenic body type | |
| JP2016210758A5 (en) | ||
| NZ767296A (en) | Liquid inhalation formulation comprising rpl554 | |
| WO2015128403A3 (en) | An a22k, desb27, b29r, des b30, at epsilon position of lysine 22 acylated human insulin analogue | |
| JP2014139182A5 (en) | ||
| JP2010531320A5 (en) | ||
| WO2018093237A3 (en) | Composition comprising formic acid or pharmaceutically acceptable salt thereof as active ingredient for preventing or treating obesity or metabolic syndromes caused by obesity | |
| WO2011118957A3 (en) | Composition for treating inflammatory, allergic or asthma diseases, containing paprika extracts | |
| EP3007674B1 (en) | Novel bath salt composition | |
| CN103637967A (en) | Whitening mask | |
| CN103598985A (en) | Compounded whitening mask | |
| JP2016028097A5 (en) | ||
| ATE463225T1 (en) | PERSONAL CARE OR BEAUTY PRODUCTS | |
| CN103622894A (en) | Traditional chinese medicine whitening mask | |
| CN103585036A (en) | whitening mask | |
| Romanowski | An introduction to cosmetic technology | |
| CN103622893A (en) | Pearl powder contained mask | |
| JP3238977U (en) | dry food products | |
| JP5475311B2 (en) | Solutions for maintaining and improving physical health | |
| CN103976244A (en) | Healthcare glutinous rice dumpling with ginger and preparation method of healthcare glutinous rice dumpling with ginger | |
| CN104840779A (en) | Food for prevention and treatment of lithiasis | |
| CN103622895A (en) | Whitening and yellow-skin removing facial mask powder | |
| JPWO2019194130A5 (en) | ||
| Kilic | colchicine overdose/filgrastim | |
| JP2007082984A (en) | Health/beauty promoting material simultaneously using gold, germanium and amber |